Table 2 Changes in PSA, miTNM stage, WB-PSMA-SUVmean, and WB-PSMA-VOL between PET1 and PET2
PET1 | PET2 | % Change | |
|---|---|---|---|
Median PSA, ng/mL (range) | 4.4 (0.02–336.9) | 0.61 (0–95.1) | − 86.1 |
miTNM, n (%) | N/A | ||
T0N0M0 | 5 (14.3) | 10 (28.6) | |
TrN0M0 | 2 (5.7) | 2 (5.7) | |
N1 and / or M1a (LN disease only) | 12 (34.3) | 9 (25.7) | |
M1b (bone disease only) | 3 (8.6) | 4 (11.4) | |
N1 and/or M1a and M1b (LN + Bone disease) | 8 (22.9) | 7 (20) | |
M1c | 5 (14.3) | 3 (8.6) | |
Median WB-PSMA-SUVmean | 4.993 (0–13.023) | 3.827 (0–11.959) | − 23.4 |
Median WB-PSMA-VOL (range) | 42.404 (0–1501.644) | 5.879 (0–2371.702) | − 86.1 |